Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bcl-2 expressing T lymphocytes in multiple sclerosis lesions

U K Zettl1, T Kuhlmann, W Brück

  • 1Department of Neurology, University of Rostock, Germany.

Neuropathology and Applied Neurobiology
|August 26, 1998
PubMed
Summary

The anti-apoptotic protein bcl-2 is expressed by T lymphocytes in multiple sclerosis (MS) lesions. Higher bcl-2 levels in progressive MS suggest a role in regulating inflammatory cell persistence.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An autoantibody signature predictive for multiple sclerosis: evidence at the protein level and association with histopathological lesion types.

Journal of neurology·2026
Same author

HFE and ALK3 act in the same signaling pathway.

Free radical biology & medicine·2020
Same author

Sentiment Analysis in Children with Neurodevelopmental Disorders in an Ingroup/Outgroup Setting.

Journal of autism and developmental disorders·2019
Same author

Targeting myelin lipid metabolism as a potential therapeutic strategy in a model of CMT1A neuropathy.

Nature communications·2018
Same author

The sphingosine analog fingolimod (FTY720) enhances tone and contractility of rat gastric fundus smooth muscle.

Neurogastroenterology and motility·2018
Same author

B cells in multiple sclerosis therapy-A comprehensive review.

Acta neurologica Scandinavica·2018

Area of Science:

  • Neuroimmunology
  • Cellular Biology
  • Pathology

Background:

  • Multiple sclerosis (MS) is a central nervous system inflammatory disease.
  • T lymphocytes are key players in MS pathogenesis.
  • Mechanisms regulating inflammation in MS remain unclear, with T cell apoptosis suggested as a key factor.

Purpose of the Study:

  • To investigate the expression of the anti-apoptotic protein bcl-2 in T lymphocytes within MS lesions.
  • To compare bcl-2 expression levels between different MS subtypes and lesion stages.

Main Methods:

  • Studied 11 chronic MS patients (5 relapsing-remitting, 6 chronic progressive).
  • Analyzed 35 lesions across various demyelinating activity stages.
  • Utilized double immunocytochemistry to quantify CD 3-positive T cells and T cells expressing bcl-2.

Related Experiment Videos

Main Results:

  • Bcl-2 is expressed by T lymphocytes in MS plaques.
  • Chronic progressive MS patients showed a higher proportion of bcl-2 expressing T cells compared to relapsing-remitting patients.
  • Highest bcl-2-positive T lymphocyte counts were observed in remyelinating and demyelinated lesions, with lower numbers in active demyelinating lesions.

Conclusions:

  • Anti-apoptotic protein bcl-2 is present in MS lesions.
  • Bcl-2 expression may influence the regulation of inflammatory cell elimination or persistence in the central nervous system in MS.